01 15VERTEX PHARMS INC
01 1510239867
01 15Y
01 15Y
01 152027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10239867
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-4056
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
IVACAFTOR; IVACAFTOR, TEZACAFTOR
US Patent Number : 10239867
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210491
Patent Use Code : U-2512
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US Patent Number : 10239867
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 218730
Patent Use Code : U-4090
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10239867
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-3158
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10239867
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-4056
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10239867
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-3033
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
DEUTIVACAFTOR; TEZACAFTOR; VANZACAFTOR CALCIUM
US Patent Number : 10239867
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 218730
Patent Use Code : U-4090
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10239867
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-3590
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10239867
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 212273
Patent Use Code : U-3158
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
Patent Expiration Date : 2027-04-09
ELEXACAFTOR, IVACAFTOR, TEZACAFTOR; IVACAFTOR
US Patent Number : 10239867
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 217660
Patent Use Code : U-4053
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-09
